Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy.
about
Advances in the treatment of central serous chorioretinopathyHalf-dose verteporfin combined with half-fluence photodynamic therapy for chronic central serous chorioretinopathy.Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes.Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).Emerging roles for antiangiogenesis factors in management of ocular disease.The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.Subfoveal choroidal thickness after photodynamic therapy in patients with acute idiopathic central serous chorioretinopathyPhotodynamic therapy for central serous chorioretinopathy.Comparison of visual and anatomical outcomes of half-fluence and half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy.Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study.Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy.Long-term outcomes in half-dose verteporfin photodynamic therapy for chronic central serous retinopathy.Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms.
P2860
Q28088443-2A6597B2-2868-4CDE-A80D-2A6C8605F1C9Q33705962-9D8A1CC6-BD67-49DC-B2E1-2DF80673FA46Q34334673-0C5CD7B5-846E-4BB4-9A22-7C6B57F046F0Q36407625-D2462C38-6CD9-4B47-AA75-75ACA311768AQ36696513-0A9E4B1F-AEA1-4538-BC8F-78089CE72132Q37169814-7A8EBC0E-3264-4A50-B79C-A5D88964FE87Q37478532-ADFA2C1F-F718-4ADC-8194-15CEA6A7FD01Q38221648-33B653B2-EEF1-49CB-A109-80577788B907Q38330486-D496F979-7634-44FD-AD9C-2DAB56820C7DQ41106280-DEE63C21-FB3C-4031-A89B-D62056929660Q47104599-7BCC37AA-3C35-42F1-AB7D-1DEFC21EE6E6Q47168979-C25419C0-5FB4-414C-901C-6EA91C1D93E2Q47978328-25842229-9512-4555-B99B-4C95175FFACE
P2860
Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Half-dose vs one-third-dose ph ...... tral serous chorioretinopathy.
@ast
Half-dose vs one-third-dose ph ...... tral serous chorioretinopathy.
@en
type
label
Half-dose vs one-third-dose ph ...... tral serous chorioretinopathy.
@ast
Half-dose vs one-third-dose ph ...... tral serous chorioretinopathy.
@en
prefLabel
Half-dose vs one-third-dose ph ...... tral serous chorioretinopathy.
@ast
Half-dose vs one-third-dose ph ...... tral serous chorioretinopathy.
@en
P2093
P2860
P356
P1433
P1476
Half-dose vs one-third-dose ph ...... tral serous chorioretinopathy.
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.2012.66
P577
2012-05-01T00:00:00Z
P5875
P6179
1002847030